Recommendation ID
NG203/5
Question

Hyperphosphatemia in people with CKD stage 4 or 5: What are people with CKD and their family members and carers views and beliefs about taking oral phosphate binders?

Any explanatory notes
(if applicable)

For a short explanation of why the committee made this recommendation for research, see the rationale on hyperphosphataemia in people with CKD stage 4 or 5.

Full details of the evidence and the committee's discussion are in evidence review L: use of phosphate binders.


Source guidance details

Comes from guidance
Chronic kidney disease: assessment and management
Number
NG203
Date issued
August 2021

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 31/08/2021